Opexa Announces Top-Line Results from Phase IIb Trial
- notasperfectasyou
- Family Elder
- Posts: 802
- Joined: Thu Feb 09, 2006 3:00 pm
- Location: Northern Virginia
- Contact:
neurovax
I did a bit of googling on neurovax (the other vaccine method that was being developed by Orchestra - different approach). Looks like it is near it's end now. I don't know much about neurovax, except that it was once believed to be "THE ANSWER". I remain hopeful that there is some substance to Tovaxin. Ken
It would be really nice to be able to put links in here
If I have included a bad link, google the word "Scholar", click link for "Google Scholar". Search for the name of the paper and author in Google Scholar.
If I have included a bad link, google the word "Scholar", click link for "Google Scholar". Search for the name of the paper and author in Google Scholar.
Maybe I should shut up but I am going to give a brief summation of my phone conversation today with my Clinical staff/personal Neurologist. They were in Montreal and have spoken at length with the Opexa staff. Here's what I gather, it was not necessarily a random draw for vaccine, it appears the "worst" cases were selected. The only reason I can come up with is a black jack term "doubling down". Stunning results with the worst group makes for a stunning future. Backfire. Their opinion is that Tovaxin still has a future with mildly affected patients but NOT with advanced cases. I fall into the later group and appreciate that they have been honest with me about finding a new course. Would it be to late to ask you all to keep this between us?
Peace,
Lars
Peace,
Lars
- hmtucker
- Family Elder
- Posts: 100
- Joined: Tue Nov 28, 2006 3:00 pm
- Location: Versailles, Kentucky
- Contact:
Lars,Lars wrote:Stunning results with the worst group makes for a stunning future. Backfire. Their opinion is that Tovaxin still has a future with mildly affected patients but NOT with advanced cases.
That is an interesting interpretation and one that could easily be flipped 180° with the interpretation that Tovaxin working great for more affected cases. A 0.2 ARR for more seriously affected cases should be considered very good especially compared to other approved treatments. As an aside, many thought that the Tysabri results were fishy because many thought that the Tysabri arm was much less affected than the placebo arm.
It seems that the general problem with reaction to the top line results was that the placebo group was too low compared to the Tovaxin group giving the impression that Tovaxin didn't help out all that much. However if the two groups were indeed very different, non-randomized populations then direct comparisons are statistically invalid and meaningless.
Mike
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2028 Views
-
Last post by NHE
-
- 0 Replies
- 10610 Views
-
Last post by NHE
-
- 0 Replies
- 1101 Views
-
Last post by frodo
-
- 0 Replies
- 1455 Views
-
Last post by NHE
-
- 2 Replies
- 3848 Views
-
Last post by DIM
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 0 Replies
- 2191 Views
-
Last post by NHE
-
- 1 Replies
- 1140 Views
-
Last post by Scott1
-
- 1 Replies
- 1668 Views
-
Last post by frodo